| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
Nasdaq: DBLT |
| Security Type |
Common Stock |
| Lead Underwriter |
Lehman Brothers |
| Days In Registration |
187 |
| Date Filed |
1-Sep-2000 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2012) |
| Industry |
Pers/Bus/Rep Svc |
| Business Description |
Provide genomic information and bioinformatics analysis technologies |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
- |
| President/CEO |
John D. Couch |
| Number of Employees |
149 |
|
| Original Filing Information |
| US |
| Shares Filed |
5.0M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
750.0K |
| File Amount |
- |
| File Price Range |
$15.00 - $13.00 |
| File Mid Price |
$14.00 |
|
